Safety and Efficacy of Statins for Chinese Patients With Dyslipidemia
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
Summary
- Conditions
- Dyslipidemias
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Participants are assigned to one of two or more groups in parallel for the duration of the study.Masking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 75 years
- Gender
- Both males and females
Description
Study Objective: The main Objective: To explore the effects of different statins lipid-lowering treatment on glucose metabolism in patients with impaired glucose regulation in a large sample of Chinese population; The secondary Objective: To obtain real-world evidence of the clinical efficacy and sa...
Study Objective: The main Objective: To explore the effects of different statins lipid-lowering treatment on glucose metabolism in patients with impaired glucose regulation in a large sample of Chinese population; The secondary Objective: To obtain real-world evidence of the clinical efficacy and safety of statins lipid-lowering therapy in Chinese patients. Study Design: The study was an open-label, multi-center network register-based follow-up study. The total sample size: 10000 participants.
Tracking Information
- NCT #
- NCT03418974
- Collaborators
- Peking University People's Hospital
- Jiangsu Wanbang Medicine Marketing Co., Ltd.
- Investigators
- Principal Investigator: Yuming Jin, Professor School of Public Health, Fudan University Principal Investigator: Dayi Hu, Professor Director of Department of Cardiology, Peking University People's Hospital; Director of Institute of Cardiovascular Disease, Peking University
Get Well Soon